XML 24 R10.htm IDEA: XBRL DOCUMENT v3.21.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Oct. 31, 2019
Operating Activities:      
Net income from consolidated operations $ 329,758 $ 335,855 $ 359,741
Adjustments to reconcile net income from consolidated operations to net cash provided by operating activities:      
Depreciation and amortization 93,019 88,561 83,497
Share-based compensation expense 9,058 10,134 10,334
Employer contributions to HEICO Savings and Investment Plan 10,091 9,576 9,528
Deferred Income Taxes and Tax Credits (15,635) (5,998) (6,392)
Increase in accrued contingent consideration 1,246 515 2,630
Payment of contingent consideration   (175) (3,105)
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (27,300) 71,515 (28,976)
Contract assets 376 (16,398) 11,583
Inventories (10,121) (28,315) (30,077)
Prepaid expenses and other current assets (4,795) 2,471 609
Trade accounts payable 6,907 (30,327) (3,851)
Accrued expenses and other current liabilities 33,634 (37,905) 17,151
Income taxes payable 2,821 (9,586) 1,296
Change in long-term liabilities and assets related to HEICO LCP 12,781 14,836 12,920
Other 2,244 4,366 490
Net cash provided by operating activities 444,084 409,125 437,378
Investing Activities:      
Acquisitions, net of cash acquired (136,500) (163,939) (240,841)
Capital expenditures (36,183) (22,940) (28,938)
Net Investment Related to HEICO LCP (14,000) (15,900) (13,701)
Other 3,229 3,736 2,834
Net cash used in investing activities (183,454) (199,043) (280,646)
Financing Activities:      
Payments on revolving credit facility (505,000) (68,000) (283,000)
Borrowings on revolving credit facility 0 245,000 313,000
Distributions to noncontrolling interests (27,963) (17,908) (110,869)
Cash dividends paid (23,002) (21,552) (18,691)
Redemption of common stock related to stop option exercises (3,791) (12,120) (64,014)
Acquisitions of noncontrolling interests (2,336) (7,475) 0
Revolving credit facility issuance costs (1,468) 0 0
Payment of contingent consideration 0 (325) (4,073)
Proceeds from stock option exercises 5,344 6,955 8,547
Proceeds from Noncontrolling Interests 534 14,329 0
Other (1,286) (1,161) (620)
Net cash (used in) provided by financing activities (558,968) 137,743 (159,720)
Effect of exchange rate changes on cash (216) 2,026 390
Net increase (decrease) in cash and cash equivalents (298,554) 349,851 (2,598)
Cash and cash equivalents at beginning of year 406,852 57,001 59,599
Cash and cash equivalents at end of year $ 108,298 $ 406,852 $ 57,001